Dobutamine/levosimendan/milrinoneLack of efficacy

被引：0
|
作者：
机构：
来源：
Reactions Weekly | 2024年 / 2014卷 / 1期
关键词：
D O I：
10.1007/s40278-024-61667-1
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：239 / 239
相关论文
共 50 条
  • [41] Levosimendan Plus Dobutamine in Acute Decompensated Heart Failure Refractory to Dobutamine
    Juguet, William
    Fard, Damien
    Faivre, Laureline
    Koutsoukis, Athanasios
    Deguillard, Camille
    Mongardon, Nicolas
    Mekontso-Dessap, Armand
    Huguet, Raphaelle
    Lim, Pascal
    JOURNAL OF CLINICAL MEDICINE, 2020, 9 (11) : 1 - 11
  • [42] Efficacy and safety of intermittent, long-term, concomitant dobutamine and levosimendan infusions in severe heart failure refractory to dobutamine alone
    Nanas, JN
    Papazoglou, P
    Tsagalou, EP
    Ntalianis, A
    Tsolakis, E
    Terrovitis, JV
    Kanakakis, J
    Nanas, SN
    Alexopoulos, GP
    Anastasiou-Nana, MI
    AMERICAN JOURNAL OF CARDIOLOGY, 2005, 95 (06) : 768 - 771
  • [43] MilrinoneLack of efficacy: 4 case reports
    Reactions Weekly, 2024, 2023 (1) : 245 - 245
  • [44] Epinephrine/milrinoneLack of efficacy: case report
    Reactions Weekly, 2020, 1822 (1) : 131 - 131
  • [45] Digoxin/milrinoneLack of efficacy: case report
    Reactions Weekly, 2021, 1883 (1) : 154 - 154
  • [46] LEVOSIMENDAN VS. DOBUTAMINE IN SEPTIC SHOCK
    Alhashemi, Jamal A.
    Alotaibi, Qamar A.
    Abdullah, Ghadah M.
    Shalabi, Sanaa A.
    CRITICAL CARE MEDICINE, 2008, 36 (12) : A158 - A158
  • [47] The levosimendan facilitates the weaning of the dobutamine in patients with severe heart failure and dependant on dobutamine
    Petipe, C.
    Mewton, N.
    Abdelaoui, M.
    Debreyne, B.
    Belot, A.
    Sanchez, I.
    Billard, M.
    Francois, L.
    Kirkorian, G.
    Bonnefoy-Cudraz, E.
    EUROPEAN HEART JOURNAL, 2008, 29 : 303 - 303
  • [48] Norepinephrine, vasopressin and milrinoneLack of efficacy: case report
    Reactions Weekly, 2021, 1856 (1) : 324 - 324
  • [49] Amiodarone/milrinoneLack of efficacy: 7 case reports
    Reactions Weekly, 2022, 1901 (1) : 47 - 47
  • [50] Bivalirudin/furosemide/milrinoneLack of efficacy : case report
    Reactions Weekly, 2024, 2018 (1) : 91 - 91
12345